Autoimmune patients in CAR-T study see striking improvements across lupus and other diseases
SAN DIEGO — All of the first 15 autoimmune disease patients who received CAR-T therapy at a German hospital saw the debilitating symptoms of their diseases, including lupus and myositis, substantially improve or go away entirely, according to new research results shared Saturday.
In 2021, a team of researchers from the University Hospital Erlangen began the first study of CAR-T therapy in patients with autoimmune diseases, making waves across the field when they announced that the first five patients with lupus all went into remission.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.